ANI Pharmaceuticals

ANI Pharmaceuticals ANIP Stock

$71.08   1.267986%
Add to favorites
Market Cap
$1.63B
LOW - HIGH [24H]
$70.27 - $71.87
VOLUME [24H]
$127.93K
P/E Ratio
15.48
Earnings per share
$4.59
ISIN
US00182C1036
Price   Prediction

ANI Pharmaceuticals Price Chart

Sorry, that's all we've gotfor now...

ANI Pharmaceuticals ANIP Financial and Trading Overview

ANI Pharmaceuticals stock price 71.08 USD
Previous Close 70.19 USD
Open 70.89 USD
Bid 56.91 USD x 200
Ask 103.53 USD x 200
Day's Range 70.27 - 71.39 USD
52 Week Range 69.58 - 99.39 USD
Volume 26.51K USD
Avg. Volume 347.11K USD
Market Cap 1.63B USD
Beta (5Y Monthly) 0.45
PE Ratio (TTM) 15.501089
EPS (TTM) 4.59 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 108.38 USD

ANIP Valuation Measures

Enterprise Value 1.75B USD
Trailing P/E 15.501089
Forward P/E 6.7856846
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 1.6704576
Price/Book (mrq) 2.5532908
Enterprise Value/Revenue 1.792
Enterprise Value/EBITDA 8.372

Trading Information

ANI Pharmaceuticals Stock Price History

Beta (5Y Monthly) 0.45
52-Week Change -28.96%
S&P500 52-Week Change 15.74%
52 Week High 99.39 USD
52 Week Low 69.58 USD
50-Day Moving Average 77.56 USD
200-Day Moving Average 79.14 USD

ANIP Share Statistics

Avg. Volume (3 month) 347.11K USD
Avg. Daily Volume (10-Days) 327.89K USD
Shares Outstanding 22.96M
Float 19.65M
Short Ratio 8.22
% Held by Insiders 5.44%
% Held by Institutions 107.04%
Shares Short 3.36M
Short % of Float 17.84%
Short % of Shares Outstanding 14.64%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:6

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) June 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 11.07%
Operating Margin (ttm) 14.97%
Gross Margin 60.40%
EBITDA Margin 21.40%

Management Effectiveness

Return on Assets (ttm) 5.44%
Return on Equity (ttm) 20.45%

Income Statement

Revenue (ttm) 978.38M USD
Revenue Per Share (ttm) 47.24 USD
Quarterly Revenue Growth (yoy) 25.90%
Gross Profit (ttm) 590.98M USD
EBITDA 209.41M USD
Net Income Avi to Common (ttm) 99.6M USD
Diluted EPS (ttm) 4.59
Quarterly Earnings Growth (yoy) 189.09%

Balance Sheet

Total Cash (mrq) 376.96M USD
Total Cash Per Share (mrq) 17.59 USD
Total Debt (mrq) 626.03M USD
Total Debt/Equity (mrq) 104.83 USD
Current Ratio (mrq) 2.91
Book Value Per Share (mrq) 27.866

Cash Flow Statement

Operating Cash Flow (ttm) 189.47M USD
Levered Free Cash Flow (ttm) 132.21M USD

Profile of ANI Pharmaceuticals

Country United States
State MN
City Baudette
Address 210 Main Street West
ZIP 56623
Phone 218 634 3500
Website https://www.anipharmaceuticals.com
Industry Drug Manufacturers - Specialty & Generic
Sector(s) Healthcare
Full Time Employees 970

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Q&A For ANI Pharmaceuticals Stock

What is a current ANIP stock price?

ANI Pharmaceuticals ANIP stock price today per share is 71.08 USD.

How to purchase ANI Pharmaceuticals stock?

You can buy ANIP shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for ANI Pharmaceuticals?

The stock symbol or ticker of ANI Pharmaceuticals is ANIP.

Which industry does the ANI Pharmaceuticals company belong to?

The ANI Pharmaceuticals industry is Drug Manufacturers - Specialty & Generic.

How many shares does ANI Pharmaceuticals have in circulation?

The max supply of ANI Pharmaceuticals shares is 22.97M.

What is ANI Pharmaceuticals Price to Earnings Ratio (PE Ratio)?

ANI Pharmaceuticals PE Ratio is 15.48583900 now.

What was ANI Pharmaceuticals earnings per share over the trailing 12 months (TTM)?

ANI Pharmaceuticals EPS is 4.59 USD over the trailing 12 months.

Which sector does the ANI Pharmaceuticals company belong to?

The ANI Pharmaceuticals sector is Healthcare.

ANI Pharmaceuticals ANIP included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.symbol }} {{ item.name }} {{ item.symbol }} {{ item.country.toUpperCase() }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
us US Tech Composite IXIC US 26281.44 USD
-0.2
4.28B USD 25992.55 USD 26329.98 USD 4.28B USD
us US Tech Biotechnology Total Retu XNBI US 7628.86 USD
+0.87
7562.12 USD 7658.89 USD
us US Tech Global Market Composite NQGM US 2220.91 USD
+0.21
2197.04 USD 2231.45 USD
us US Tech Biotechnology NBI US 6984.28 USD
+0.86
6923.95 USD 7012.55 USD
us US Tech Health Care IXHC US 1306.18 USD
+0.97
1296.22 USD 1310.89 USD
us US Tech Composite Total Return XCMP US 32454.52 USD
-0.2
32099.52 USD 32516.23 USD
us Stlmt ID US Tech Biotechnology NBX US 4000.62 USD
-1.26
3927.42 USD 4148.65 USD
$2.71T
Total marketcap
$81.4B
Total volume
BTC 58.55%     ETH 11.42%
Dominance
Select currency